MX3170E - Procedimiento para la preparacion de anilidas de acido 2 - hidroxi etil idenciano acetico - Google Patents
Procedimiento para la preparacion de anilidas de acido 2 - hidroxi etil idenciano aceticoInfo
- Publication number
- MX3170E MX3170E MX000269U MX26976U MX3170E MX 3170 E MX3170 E MX 3170E MX 000269 U MX000269 U MX 000269U MX 26976 U MX26976 U MX 26976U MX 3170 E MX3170 E MX 3170E
- Authority
- MX
- Mexico
- Prior art keywords
- formula
- see
- carbon atoms
- acid
- alcohol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/66—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pain & Pain Management (AREA)
- Public Health (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se refiere a un procedimiento para la preparación de anilidas de ácido 2-hidroxietilidenciano acético, de la fórmula I (VER FIGURA) en donde R1, R2 y R3 pueden ser iguales o diferentes y significan alcohilo con 1, 2 ó 3 átomos de carbono, alcoxi con 1, 2 ó 3 átomos de carbono, alcohiltio con 1, 2 ó 3 átomos de carbono, pudiendo estar sustituídos estos grupos en cada caso, total o parcialmente, con átomos de halógeno iguales o diferentes, o significan halógeno, nitro, ciano, carbalcoxi, con 1, 2 ó 3 átomos de carbono en el grupo alcohilo, en donde R1 y R2 significan además hidrógeno, pero en cuyo caso R3 no puede ser metilo, en cuyo caso no obstante R3 significa adicionalmente fenilo, que en cada caso puede estar sustituído eventualmente una o dos veces con flúor, cloro, bromo, yodo, alcohilo con 1, 2 ó 3 átomos de carbono o alcoxi con 1, 2 ó 3, átomos de carbono, o en donde R1 significa hidrógeno y R2 y R3 significan en común un grupo metilendioxi, o en común con el anillo fenilo que los lleva significan un anillo naftaleno, y en donde M significa hidrógeno, un metal alcalino o amonio; caracterizado porque se calienta una anilida de ácido acetoacético de la fórmula II (VER FIGURA) en donde R1, R2 y R3 tienen los significados arriba mencionados, con un ortoéster de ácido fórmico de la fórmula III (VER FIGURA)en donde R significa alcohilo C1 hasta C4, y con anídrido de ácido acético, se aísla la anilida de ácido 2-alcoximetilen acetoacético así obtenida de la fórmula IV. (VER FIGURA) en donde R1, R2 y R3 tienen los significados arriba mencionados, se trata el compuesto aislado con hidroxilamina en un disolvente orgánico y se trata el isoxazol así obtenido de la fórmula V. (VER FIGURA) con una base, y eventualmente los compuestos de metal alcalino o de amonio de la fórmula I, así obtenidos se hacen reaccionar con un ácido mineral o con un ácido orgánico fuerte.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2524929A DE2524929C3 (de) | 1975-06-05 | 1975-06-05 | 2-Hydroxyäthylidencyanessigsäureanilide, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Mittel |
Publications (1)
Publication Number | Publication Date |
---|---|
MX3170E true MX3170E (es) | 1980-06-05 |
Family
ID=5948272
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX000269U MX3170E (es) | 1975-06-05 | 1976-06-04 | Procedimiento para la preparacion de anilidas de acido 2 - hidroxi etil idenciano acetico |
Country Status (15)
Country | Link |
---|---|
US (1) | US4061767A (es) |
JP (1) | JPS6032620B2 (es) |
AT (1) | AT343641B (es) |
BE (1) | BE842688A (es) |
CA (1) | CA1082202A (es) |
CH (1) | CH627444A5 (es) |
DE (1) | DE2524929C3 (es) |
DK (1) | DK157078C (es) |
FR (1) | FR2313031A1 (es) |
GB (1) | GB1555555A (es) |
IE (1) | IE43004B1 (es) |
IT (1) | IT1063593B (es) |
LU (1) | LU75075A1 (es) |
MX (1) | MX3170E (es) |
NL (2) | NL186239C (es) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55500866A (es) * | 1978-11-03 | 1980-10-30 | ||
US4173650A (en) * | 1978-11-03 | 1979-11-06 | American Cyanamid Company | Cis-2-benzoyl-3-hydroxy-2-alkenonitriles as anti-inflammatory agents |
US4181677A (en) * | 1978-12-13 | 1980-01-01 | American Cyanamid Company | 2-Benzoyl-3-alkoxy-2-alkenonitriles |
US4259256A (en) * | 1978-12-13 | 1981-03-31 | American Cyanamid Company | 2-Benzoyl-3-dimethylamino-2-alkenonitriles |
PT71367A (en) * | 1979-06-11 | 1980-07-01 | Ciba Geigy Ag | Process for preparing alphacarbamoyl-pyrrolpropionitriles |
US4256759A (en) * | 1979-06-11 | 1981-03-17 | Ciba-Geigy Corporation | Alphacarbamoyl-pyrrolpropionitriles |
US4277420A (en) * | 1979-09-24 | 1981-07-07 | Monsanto Company | Ephedrine and pseudoephedrine precursors |
US4254048A (en) * | 1979-12-17 | 1981-03-03 | American Cyanamid Company | Substituted phenyl alkylidene acetoacetonitriles |
US4254047A (en) * | 1979-12-17 | 1981-03-03 | American Cyanamid Company | Substituted phenyl-2-cyano-2-thioalkenoic acid esters |
US4254049A (en) * | 1979-12-17 | 1981-03-03 | American Cyanamid Company | Substituted phenyl-2-cyano-2-alkenoic acid esters |
US4435407A (en) | 1982-01-07 | 1984-03-06 | Ciba-Geigy Corporation | Certain substituted β-oxo-α-carbamoylpyrrolepropionitriles |
US4644010A (en) * | 1982-09-28 | 1987-02-17 | Ciba-Geigy Corporation | Certain β-oxo-α-carbamoylpyrrolepropionitriles |
DE3247454A1 (de) * | 1982-12-22 | 1984-06-28 | Laboratorios Bago S.A., Buenos Aires | Substituierte 3-phenyl-5-methyl-isoxazol-4-carboxy-anilide, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
DE3534440A1 (de) * | 1985-09-27 | 1987-04-02 | Hoechst Ag | Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes |
US5268382A (en) * | 1985-09-27 | 1993-12-07 | Hoechst Aktiengesellschaft | Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus |
GB8619432D0 (en) * | 1986-08-08 | 1986-09-17 | Lilly Industries Ltd | Pharmaceutical compounds |
GB8619433D0 (en) * | 1986-08-08 | 1986-09-17 | Lilly Industries Ltd | Pharmaceutical compounds |
US4888357A (en) * | 1988-01-26 | 1989-12-19 | Bristol-Myers Company | Antiarthritic β-cycloalkyl-β-oxopropionitriles |
US4975462A (en) * | 1988-07-29 | 1990-12-04 | Bristol-Myers Company | Antiarthritic α-arylcarbamoyl cyanoacetic acid derivatives |
US5583150A (en) * | 1989-08-18 | 1996-12-10 | Alcon Laboratories, Inc. | 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic anilides for the treatment of ocular diseases |
DD297328A5 (de) | 1989-08-18 | 1992-01-09 | �������@���������k���Kk�� | 5-methyl-isoxalol-4-carbonsaeureanilide und 2 hydroxyethyliden-cyanoessigsaeureanilide zur behandlung von augenerkrankungen |
US5034410A (en) * | 1989-10-11 | 1991-07-23 | Syntex (U.S.A.) Inc. | Anthelmintically active benzenepropanamide derivatives |
ZA913762B (en) | 1990-05-18 | 1992-01-29 | Hoechst Ag | Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides,pharmaceuticals containing these compounds and their use |
HU222234B1 (hu) * | 1990-05-18 | 2003-05-28 | Aventis Pharma Deutschland Gmbh. | Eljárás izoxazol-4-karbonsav-amidok és hidroxi-alkilidén-cián-ecetsav-amidok, a vegyületeket tartalmazó gyógyászati készítmények és az ismert vegyületeket tartalmazó rákellenes hatású gyógyszerkészítmények előállítására |
ATE141950T1 (de) * | 1990-12-24 | 1996-09-15 | Hoechst Ag | Verfahren zur acylierung von alkoholen mit einem immobilisierten pseudomonas-lipase |
US6133301A (en) * | 1991-08-22 | 2000-10-17 | Aventis Pharma Deutschland Gmbh | Pharmaceuticals for the treatment of rejection reactions in organ transplantations |
DE4127737A1 (de) * | 1991-08-22 | 1993-02-25 | Hoechst Ag | Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen |
IL102790A (en) * | 1991-09-17 | 1996-01-31 | Roussel Uclaf | History of 3-cycloalkyl-prop-2-anamide |
ATE128353T1 (de) * | 1991-10-23 | 1995-10-15 | Hoechst Ag | N-phenyl-2-cyano-3-hydroxycrotonsäureamidderiva e und deren verwendung als arzneimittel mit immunmodulatorischer eigenschaft. |
GB9200275D0 (en) * | 1992-01-08 | 1992-02-26 | Roussel Lab Ltd | Chemical compounds |
GB9209330D0 (en) * | 1992-04-30 | 1992-06-17 | Roussel Lab Ltd | Chemical compounds |
GB9300083D0 (en) | 1993-01-05 | 1993-03-03 | Roussel Lab Ltd | Chemical compounds |
TW314467B (es) * | 1993-03-31 | 1997-09-01 | Hoechst Ag | |
RU2139092C1 (ru) * | 1993-06-03 | 1999-10-10 | Терапьютик Антибодиз Инк. | Фрагменты антител в терапии |
GB9313365D0 (en) * | 1993-06-29 | 1993-08-11 | Roussel Lab Ltd | Chemical compounds |
GB9322781D0 (en) * | 1993-11-04 | 1993-12-22 | Roussel Lab Ltd | Aromatic amides |
LT3589B (en) | 1993-11-30 | 1995-12-27 | Hoechst Ag | Using of known combination for treatment of rejection reaction by transplantation of organs |
US5700823A (en) * | 1994-01-07 | 1997-12-23 | Sugen, Inc. | Treatment of platelet derived growth factor related disorders such as cancers |
US5519042A (en) * | 1994-01-13 | 1996-05-21 | Hoechst Aktiengesellschaft | Method of treating hyperproliferative vascular disease |
US6331555B1 (en) | 1995-06-01 | 2001-12-18 | University Of California | Treatment of platelet derived growth factor related disorders such as cancers |
DE19539638A1 (de) * | 1995-10-25 | 1997-04-30 | Hoechst Ag | Die Verwendung von Isoxazol- und Crotonsäureamidderivaten zur Behandlung von Krebserkrankungen |
DE19547648A1 (de) * | 1995-12-20 | 1997-06-26 | Hoechst Ag | Zubereitung, enthaltend High Density Lipoproteine und Crotonsäureamidderivate |
US6011051A (en) * | 1996-07-31 | 2000-01-04 | Hoechst Aktiengesellschaft | Use of isoxazole and crotonamide derivatives for the modulation of apoptosis |
US5856330A (en) * | 1996-07-31 | 1999-01-05 | Hoechst Aktiengesellschaft | Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin |
US5981536A (en) * | 1996-07-31 | 1999-11-09 | Hoechst Aktiengesellschaft | Use of xanthine derivatives for the modulation of apoptosis |
US6316479B1 (en) | 1997-05-19 | 2001-11-13 | Sugen, Inc. | Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders |
ATE207065T1 (de) | 1997-08-08 | 2001-11-15 | Aventis Pharma Gmbh | Kristallform von n-(4-trifluormethylphenyl)-5- methylisoxazol-4-carbonsäureamid |
US6355678B1 (en) | 1998-06-29 | 2002-03-12 | Parker Hughes Institute | Inhibitors of the EGF-receptor tyrosine kinase and methods for their use |
US20050255071A1 (en) * | 1998-12-10 | 2005-11-17 | Aventis Pharma Deutschland Gmbh | Preparation having improved therapeutic breadth comprising nucleotide synthesis inhibitors |
GB0123571D0 (en) * | 2001-04-05 | 2001-11-21 | Aventis Pharm Prod Inc | Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis |
DE10132308A1 (de) * | 2001-07-06 | 2003-01-30 | Aventis Behring Gmbh | Kombinationspräparat zur Therapie von immunologischen Erkrankungen |
MXPA04000224A (es) | 2001-07-10 | 2005-07-25 | 4Sc Ag | Novedosos compuestos como agentes antiinflamatorios, inmunomoduladores y antiproliferativos. |
US20050158371A1 (en) * | 2002-02-12 | 2005-07-21 | Sumitomo Pharmaceuticals Co., Ltd. | Novel external agent |
RU2367650C2 (ru) | 2002-12-23 | 2009-09-20 | 4Ск Аг | Циклоалкендикарбоновые кислоты как противовоспалительные, иммуномодулирующие и антипролиферативные средства |
UA108760C2 (uk) | 2010-07-01 | 2015-06-10 | Кальцієві солі сполуки як протизапальні, імуномодулюючі та антипроліферативні засоби | |
WO2015077535A2 (en) | 2013-11-22 | 2015-05-28 | Genzyme Corporation | Novel methods for treating neurodegenerative diseases |
IL307422A (en) | 2018-03-16 | 2023-12-01 | Immunic Ag | Polymorphs of the calcium salts that suppress dihydrouroatate dehydrogenase, and methods for their production |
US11376232B2 (en) | 2020-04-21 | 2022-07-05 | Immunic Ag | Vidofludimus for use in the treatment or prevention of viral diseases |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2288863A (en) * | 1940-02-27 | 1942-07-07 | Hoffmann La Roche | Process for the manufacture of substituted amides of 3,5-dimethylisoxazole-4-carboxylic acid |
BE506549A (es) * | 1950-10-19 |
-
0
- NL NLAANVRAGE7605845,A patent/NL186239B/xx unknown
-
1975
- 1975-06-05 DE DE2524929A patent/DE2524929C3/de not_active Expired
-
1976
- 1976-05-31 NL NLAANVRAGE7605845,A patent/NL186239C/xx not_active IP Right Cessation
- 1976-06-02 CH CH696376A patent/CH627444A5/de not_active IP Right Cessation
- 1976-06-03 IT IT23922/76A patent/IT1063593B/it active
- 1976-06-03 LU LU75075A patent/LU75075A1/xx unknown
- 1976-06-03 US US05/692,318 patent/US4061767A/en not_active Expired - Lifetime
- 1976-06-04 JP JP51065477A patent/JPS6032620B2/ja not_active Expired
- 1976-06-04 DK DK248476A patent/DK157078C/da active
- 1976-06-04 IE IE1203/76A patent/IE43004B1/en unknown
- 1976-06-04 FR FR7617042A patent/FR2313031A1/fr active Granted
- 1976-06-04 AT AT413576A patent/AT343641B/de not_active IP Right Cessation
- 1976-06-04 CA CA254,136A patent/CA1082202A/en not_active Expired
- 1976-06-04 MX MX000269U patent/MX3170E/es unknown
- 1976-06-07 GB GB23437/76A patent/GB1555555A/en not_active Expired
- 1976-06-08 BE BE167706A patent/BE842688A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
GB1555555A (en) | 1979-11-14 |
LU75075A1 (es) | 1977-03-07 |
DE2524929B2 (de) | 1980-01-31 |
JPS6032620B2 (ja) | 1985-07-29 |
DK157078C (da) | 1990-04-09 |
FR2313031B1 (es) | 1979-10-12 |
DK248476A (da) | 1976-12-06 |
FR2313031A1 (fr) | 1976-12-31 |
NL7605845A (en) | 1976-12-07 |
DE2524929A1 (de) | 1976-12-16 |
CH627444A5 (de) | 1982-01-15 |
JPS527929A (en) | 1977-01-21 |
IE43004B1 (en) | 1980-12-03 |
ATA413576A (de) | 1977-10-15 |
IT1063593B (it) | 1985-02-11 |
NL186239B (nl) | |
CA1082202A (en) | 1980-07-22 |
BE842688A (fr) | 1976-12-08 |
DK157078B (da) | 1989-11-06 |
US4061767A (en) | 1977-12-06 |
DE2524929C3 (de) | 1980-10-09 |
AT343641B (de) | 1978-06-12 |
IE43004L (en) | 1976-12-05 |
NL186239C (nl) | 1990-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX3170E (es) | Procedimiento para la preparacion de anilidas de acido 2 - hidroxi etil idenciano acetico | |
MX3144E (es) | Procedimiento para la preparacion de anilidas de acido 5 - metil - isoxazol - 4 - carboxilico | |
GB967483A (es) | ||
Wang et al. | Mechanistic insights into a catalyst-free method to construct quinazolinones through multiple oxidative cyclization | |
GB1099244A (en) | Derivatives of 2,3-dihydro-1,4-oxathiin and processes for their preparation | |
AR003328A1 (es) | Proceso para la preparacion de nitro-sustituido-difenileteres, utiles como herbicidas o como intermediarios en la sintesis de herbicidas | |
Finkelstein et al. | Ring-chain tautomers of 6-substituted 2-acetylbenzoic acids | |
Obara et al. | The Photochemical Fries Rearrangement of Phenyl Cinnamate | |
ES2180186T3 (es) | Procedimiento de nitracion para difenil-eteres. | |
GB827437A (en) | New derivatives of benzodioxan | |
ES448385A1 (es) | Procedimiento para la preparacion de anilinas de acido 2-hi-droxietilidenciano-acetico. | |
KR920009040B1 (ko) | 안트라센 유도체의 제조방법 | |
ES553675A0 (es) | Un procedimiento para preparar nuevos esteres de acido androstano-17b-carboxilico | |
KLAGER | THE CHEMISTRY OF ALIPHATIC DINITRO COMPOUNDS. II. METHYL δ-HYDROXY-γ, γ-DINITROVALERATE1 | |
Giricheva et al. | Effects of the Solvent and the Nucleophile on the Photochemical Synthesis of Azepines | |
Lee et al. | N‐(2‐hydroxyaryl) benzamide synthesis from 2‐nitroaryl benzoates via an indium‐mediated reduction‐migration reaction | |
ES386022A1 (es) | Procedimiento para la obtencion de derivados de 2 (ih)-qui-nazolinona. | |
SU534455A1 (ru) | Способ получени -незамещенных солей 2,4-диарилпирили | |
MX3479E (es) | Proceso para preparar un compuesto de n-oxido de 2-sulfinil o 2-sulfonil-piridina | |
JPS5640634A (en) | Cyclohexane derivative, its preparation, and pharmaceutical containing the same | |
Burdge et al. | Esters of Naphthalenedicarboxylic Acids. | |
Subba Rao et al. | Search for physiologically active compounds. Part V. Synthesis of nitro coumarins | |
HUP0003321A2 (hu) | Eljárás 2-alkiltiobenzonitril-származékok előállítására | |
MX3366E (es) | Procedimiento para la preparacion de acidos omega-(6,11-dihidro-11-oxodibenz ( b,e,) oxepin-2-il) - alcanoicos | |
Li et al. | Synthesis of 5-nitrofurfural diacetate and 5-nitrofurfural semicarbazone: An undergraduate laboratory experiment |